⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNA News
Avidity Biosciences, Inc. Common Stock
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
globenewswire.com
NVS
RNA
Form 8-K
sec.gov
RNA
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
prnewswire.com
RNA
Form 8-K
sec.gov
RNA
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
prnewswire.com
RNA
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
prnewswire.com
RNA
Avidity Biosciences Announces Expected Record Date for Spin-Off
prnewswire.com
RNA
Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Shareholders to Contact the Firm to Discuss Their Rights
globenewswire.com
TWO
TBN
CVBF
RNA
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO
prnewswire.com
TWO
NWE
RNA
TBHC
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
accessnewswire.com
SNOA
RNA